Triple-negative breast cancer: a clinical update
Author:
- Darrel W. CleereDCDarrel W. Cleere
- 1 May 2010
- journal article
- Published by Elsevier in Community Oncology
- Vol. 7 (5) , 203-211
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- High prevalence of triple‐negative tumors in an urban cancer centerCancer, 2008
- Early onset of breast cancer in a group of British black womenBritish Journal of Cancer, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerNew England Journal of Medicine, 2007
- Epidemiology of basal-like breast cancerBreast Cancer Research and Treatment, 2007
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesHuman Pathology, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast CancerJAMA, 2006
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003